Nrx Pharmaceuticals Inc Share Price

NASDAQ: NRXP

Small Cap

$2.78

-0.10

(-3.47%)

as on September 13, 2025 at 1:29 am IST

$₹

Nrx Pharmaceuticals Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$2.73
Day's Price Range
$2.9
$2.78
1.80%
Downside
4.32%
Upside
52 Week's Low
52 Week's High
$1.1
52-Week Price Range
$6.01
$2.78
60.43%
Downside
116.19%
Upside

Nrx Pharmaceuticals Inc share price movements today

Previous Close: $2.88
Open: $2.89
Volume: 659.4K
Day's Low - High: $2.73 - $2.9
52 Week Low - High: $1.1 - $6.01

Nrx Pharmaceuticals Inc Historical Returns

1 Month Return: + 10.67 %
3 Month Return: -18.6 %
1 Year Return: + 62.79 %
3 Year Return: -62.77 %
5 Year Return: 0 %

Nrx Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Nrx Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$68.5M

EPS (TTM)

-0.57

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-14.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

18688100.00%

Nrx Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nrx Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Nrx Pharmaceuticals Inc	BUY	$68.5M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for Nrx Pharmaceuticals Inc Stock including INR - Dollar returns

The Nrx Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Nrx Pharmaceuticals Inc investment value today

Current value as on today

₹1,66,767

Returns

₹66,767

(+66.77%)

Returns from Nrx Pharmaceuticals Inc Stock

₹61,628 (+61.63%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Nrx Pharmaceuticals Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Nrx Pharmaceuticals Inc. Average target price of $36.25

Nrx Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Nrx Pharmaceuticals Inc.

What analysts predicted

92.33%UPSIDE

Target Price

$36.25

Current Price

$2.78

Analyzed by

9 Analysts

Target

$36.25

Nrx Pharmaceuticals Inc target price $36.25, a slight upside of 92.33% compared to current price of $2.78. According to 9 analysts rating.

Nrx Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Nrx Pharmaceuticals Inc Stock has increased by 125% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 15, 2025 to September 14, 2025

Change:125% versus previous 30 day period

Nrx Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	0	-	-	0	0	-
Gross Profit	0	0	0	0	0	0	0	0	0	-
Operating Income	-9	-8	-5	-4	-5	-7	-3	-2	-3	-3
EBITDA	-11	-8	-6	-4	-6	-7	-1	-9	-5	-17
Interest Expense	1	-	0	0	0	0	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	-	-
Income Before Tax	-11	-8	-6	-4	-6	-7	-1	-9	-5	-17
Income Tax Expense	1	0	0	-1	0	-	-	-	-	-
Net Income	-11	-8	-6	-4	-6	-7	-1	-9	-5	-17
Net Profit Margin	0.00%	0.00%	0.00%	-54150.00%	-81600.00%	0.00%	0.00%	-226950.00%	-137800.00%	0.00%

Nrx Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-
Gross Profit	0	0	0	0	0
Operating Income	-11	-115	-44	-27	-18
EBITDA	-51	-93	-39	-30	-24
Interest Expense	0	0	4	0	1
Depreciation	0	0	0	0	0
Income Before Tax	-51	-93	-39	-30	-25
Income Tax Expense	-39	-21	-4	0	-
Net Income	-51	-93	-39	-30	-25
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Nrx Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-8	-6	-4	-6	-7	-1	-9	-5	-17
Operating Cash Flow	-7	-4	-3	-3	-3	-2	-2	-3	-4
Investing Cash Flow	0	0	-	0	-	-	-	-	-
Financing Cash Flow	6	-1	-1	0	3	2	1	7	1
Change in Cash	-1	-6	-4	-3	0	0	0	4	-2

Nrx Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	0	-51	-93	-39	-30	-25
Operating Cash Flow	0	-2	-37	-39	-21	-10
Investing Cash Flow	40	0	0	0	0	-
Financing Cash Flow	-39	3	63	32	6	7
Change in Cash	0	0	25	-7	-15	-3

Global Institutional Holdings in Nrx Pharmaceuticals Inc

Funds	Holdings
Anson Funds Management LP	6.05%
Vanguard Group Inc	1.99%
AdvisorShares Investments, LLC	1.35%
Geode Capital Management, LLC	0.69%
Marshall Wace Asset Management Ltd	0.46%

See all

Insights on Nrx Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, NRXP stock has moved up by 10.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 188.5%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 13.5%

About Nrx Pharmaceuticals Inc

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The Company has two lead compounds, NRX-100, a proprietary presentation of ketamine and NRX-101, a fixed-dose combination of D-cycloserine (DCS) and lurasidone. The Company is developing NRX-101, a Food and Drug Administration (FDA)-designated investigational therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRX-101 is a combined NMDA/5-HT2A-targeted medicine designed to address both depression and suicidal ideation, consisting of an oral, fixed dose combination of DCS and lurasidone. Its NRX-100 is racemic ketamine, which is a generic anesthetic.

Organisation	Nrx Pharmaceuticals Inc
Headquarters	1201 Orange Street, Wilmington, DE, United States, 19801
Industry	Services
CEO	Dr. Jonathan C. Javitt M.D., M.P.H.
E-voting on shares	Click here to vote

Key Management of Nrx Pharmaceuticals Inc

Name	Title
Dr. Philip T. Lavin Ph.D.	Chief Methodologist
Dr. Jonathan C. Javitt M.D., M.P.H.	Co-Founder, Chief Scientist Officer, Chairman & Interim CEO
Mr. Matthew Patrick Duffy	Chief Business Officer & Co-CEO of Hope Therapeutics
Mr. Michael S. Abrams	Chief Financial Officer
Dr. Riccardo Panicucci Ph.D.	Chief Manufacturing & Technology Officer
Suzanne Messere	Investor Relations

FAQs

What is Nrx Pharmaceuticals Inc share price today?

Nrx Pharmaceuticals Inc share price today is $2.78 as on September 13, 2025 at 1:29 am IST at the close of the market. Nrx Pharmaceuticals Inc share today touched a day high of $2.9 and a low of $2.73.

What is the 52 week high and 52 week low for Nrx Pharmaceuticals Inc share?

Nrx Pharmaceuticals Inc share touched a 52 week high of $6.01 on January 13, 2025 and a 52 week low of $1.1 on October 16, 2024. Nrx Pharmaceuticals Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $2.78,which is 53.74% down from its 52 week high and 152.73% up from its 52 week low.

What is Nrx Pharmaceuticals Inc's market capitalisation today?

Nrx Pharmaceuticals Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Nrx Pharmaceuticals Inc Stock (NRXP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nrx Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nrx Pharmaceuticals Inc Shares that will get you 0.5396 shares as per Nrx Pharmaceuticals Inc share price of $2.78 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Nrx Pharmaceuticals Inc Stock (NRXP) from India?

Indian investors can start investing in Nrx Pharmaceuticals Inc (NRXP) shares with as little as ₹88.27 or $1 (as of September 14, 2025 at 4:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Nrx Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 14, 2025 at 4:37 am IST). Based on Nrx Pharmaceuticals Inc share’s latest price of $2.78 as on September 13, 2025 at 1:29 am IST, you will get 3.5971 shares of Nrx Pharmaceuticals Inc. Learn more about fractional shares .